834 related articles for article (PubMed ID: 20181277)
1. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
[TBL] [Abstract][Full Text] [Related]
2. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis.
Paniagua RT; Sharpe O; Ho PP; Chan SM; Chang A; Higgins JP; Tomooka BH; Thomas FM; Song JJ; Goodman SB; Lee DM; Genovese MC; Utz PJ; Steinman L; Robinson WH
J Clin Invest; 2006 Oct; 116(10):2633-42. PubMed ID: 16981009
[TBL] [Abstract][Full Text] [Related]
3. Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis.
Garcia S; Hartkamp LM; Malvar-Fernandez B; van Es IE; Lin H; Wong J; Long L; Zanghi JA; Rankin AL; Masteller EL; Wong BR; Radstake TR; Tak PP; Reedquist KA
Arthritis Res Ther; 2016 Mar; 18():75. PubMed ID: 27036883
[TBL] [Abstract][Full Text] [Related]
4. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
[TBL] [Abstract][Full Text] [Related]
5. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA).
Ando W; Hashimoto J; Nampei A; Tsuboi H; Tateishi K; Ono T; Nakamura N; Ochi T; Yoshikawa H
J Bone Miner Metab; 2006; 24(4):274-82. PubMed ID: 16816921
[TBL] [Abstract][Full Text] [Related]
6. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.
Dewar AL; Cambareri AC; Zannettino AC; Miller BL; Doherty KV; Hughes TP; Lyons AB
Blood; 2005 Apr; 105(8):3127-32. PubMed ID: 15637141
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis.
Krausz S; Garcia S; Ambarus CA; de Launay D; Foster M; Naiman B; Iverson W; Connor JR; Sleeman MA; Coyle AJ; Hamann J; Baeten D; Tak PP; Reedquist KA
Ann Rheum Dis; 2012 Aug; 71(8):1402-10. PubMed ID: 22730375
[TBL] [Abstract][Full Text] [Related]
8. Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors.
Dewar AL; Domaschenz RM; Doherty KV; Hughes TP; Lyons AB
Leukemia; 2003 Sep; 17(9):1713-21. PubMed ID: 12970769
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals.
Hiraga T; Nakamura H
Int J Cancer; 2009 Jan; 124(1):215-22. PubMed ID: 18814279
[TBL] [Abstract][Full Text] [Related]
10. Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis.
Kim SJ; Chen Z; Chamberlain ND; Essani AB; Volin MV; Amin MA; Volkov S; Gravallese EM; Arami S; Swedler W; Lane NE; Mehta A; Sweiss N; Shahrara S
J Immunol; 2014 Oct; 193(8):3902-13. PubMed ID: 25200955
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice.
Koyama K; Hatsushika K; Ando T; Sakuma M; Wako M; Kato R; Haro H; Sugiyama H; Hamada Y; Ogawa H; Nakao A
Mod Rheumatol; 2007; 17(4):306-10. PubMed ID: 17694264
[TBL] [Abstract][Full Text] [Related]
12. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
13. Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients.
Kabala PA; Malvar-Fernández B; Lopes AP; Carvalheiro T; Hartgring SAY; Tang MW; Conde C; Baeten DL; Sleeman M; Tak PP; Connor J; Radstake TR; Reedquist KA; García S
Rheumatology (Oxford); 2020 Feb; 59(2):426-438. PubMed ID: 31377797
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
Crespo O; Kang SC; Daneman R; Lindstrom TM; Ho PP; Sobel RA; Steinman L; Robinson WH
J Clin Immunol; 2011 Dec; 31(6):1010-20. PubMed ID: 21847523
[TBL] [Abstract][Full Text] [Related]
15. Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis.
Akashi N; Matsumoto I; Tanaka Y; Inoue A; Yamamoto K; Umeda N; Tanaka Y; Hayashi T; Goto D; Ito S; Sekiguchi K; Sumida T
Mod Rheumatol; 2011 Jun; 21(3):267-75. PubMed ID: 21188449
[TBL] [Abstract][Full Text] [Related]
16. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
17. JTE-952 Suppresses Bone Destruction in Collagen-Induced Arthritis in Mice by Inhibiting Colony Stimulating Factor 1 Receptor.
Uesato N; Inagaki K; Miyagawa N; Kitagawa Y; Kakefuda R; Matsuo Y; Yamaguchi T; Hata T; Ikegashira K; Matsushita M
Biol Pharm Bull; 2020; 43(12):1884-1892. PubMed ID: 33268706
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.
Conway JG; McDonald B; Parham J; Keith B; Rusnak DW; Shaw E; Jansen M; Lin P; Payne A; Crosby RM; Johnson JH; Frick L; Lin MH; Depee S; Tadepalli S; Votta B; James I; Fuller K; Chambers TJ; Kull FC; Chamberlain SD; Hutchins JT
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16078-83. PubMed ID: 16249345
[TBL] [Abstract][Full Text] [Related]
19. The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.
Chang BY; Huang MM; Francesco M; Chen J; Sokolove J; Magadala P; Robinson WH; Buggy JJ
Arthritis Res Ther; 2011 Jul; 13(4):R115. PubMed ID: 21752263
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
Front Immunol; 2020; 11():613975. PubMed ID: 33679701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
